We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+4.89%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$49.6B
AUM Growth
+$4.18B
(+9.2%)
Cap. Flow
+$2.12B
Cap. Flow
% of AUM
4.28%
Top 10 Holdings %
Top 10 Hldgs %
48.74%
Holding
2,801
New
460
Increased
1,171
Reduced
766
Closed
196
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$543M |
| 2 |
Vanguard Total Bond Market
BND
|
+$516M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$207M |
| 4 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$158M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$57M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
+$55.6M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$45M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$32.5M |
| 5 |
CrowdStrike
CRWD
|
+$23.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.86% |
| 2 | Financials | 3.34% |
| 3 | Consumer Discretionary | 2.34% |
| 4 | Communication Services | 1.74% |
| 5 | Healthcare | 1.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
1901
DELISTED
Revance Therapeutics, Inc.
RVNC
| $255K | ﹤0.01% |
+9,136
| New | +$253K |
|
|
GTHX
1902
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $255K | ﹤0.01% |
10,609
-11,257
| -51% | -$262K |
|
1903
Gladstone Investment Corp
GAIN
$635M
| $254K | ﹤0.01% |
20,805
-2,001
| -9% | -$23K |
|
1904
The Mosaic Company
MOS
$7.09B
| $254K | ﹤0.01% |
+8,028
| New | +$237K |
|
|
ATAXZ
1905
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
| $254K | ﹤0.01% |
46,000
| – | – |
|
1906
Lennar Class B
LEN.B
$20B
| $253K | ﹤0.01% |
+3,237
| New | +$216K |
|
1907
NewMarket
NEU
$7.17B
| $253K | ﹤0.01% |
665
+17
| +3% | +$6.79K |
|
1908
Greenwich LifeSciences
GLSI
$191M
| $251K | ﹤0.01% |
7,351
+308
| +4% | +$10.5K |
|
1909
TD Synnex
SNX
$19.4B
| $251K | ﹤0.01% |
+2,189
| New | +$204K |
|
1910
Synaptics
SYNA
$4.41B
| $251K | ﹤0.01% |
+1,857
| New | +$226K |
|
|
MCA
1911
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
| $251K | ﹤0.01% |
17,021
-1,200
| -7% | -$17.7K |
|
1912
Butterfly Network
BFLY
$1.72B
| $250K | ﹤0.01% |
14,860
+2,643
| +22% | +$52.3K |
|
1913
Jazz Pharmaceuticals
JAZZ
$15.9B
| $250K | ﹤0.01% |
1,522
+254
| +20% | +$41.8K |
|
1914
Momentus
MNTS
$88.7M
| $250K | ﹤0.01% |
+2
| New | +$480K |
|
1915
NI Holdings
NODK
$325M
| $250K | ﹤0.01% |
13,533
| – | – |
|
1916
Bakkt Inc
BKKT
$333M
| $249K | ﹤0.01% |
+766
| New | +$286K |
|
1917
Global X SuperDividend US ETF
DIV
$787M
| $249K | ﹤0.01% |
12,843
+1,416
| +12% | +$26K |
|
1918
CALL
Uber
UBER
$134B
| $249K | ﹤0.01% |
13,200
-800
| -6% | -$44.6K |
|
1919
GATX Corp
GATX
$6.55B
| $248K | ﹤0.01% |
2,675
+1
| +0% | +$93 |
|
1920
Booz Allen Hamilton
BAH
$8.7B
| $247K | ﹤0.01% |
+3,063
| New | +$257K |
|
1921
ManpowerGroup
MAN
$2.39B
| $247K | ﹤0.01% |
2,499
+156
| +7% | +$14.9K |
|
|
PR
1922
Permian Resources
PR
$17.9B
| $247K | ﹤0.01% |
+58,819
| New | +$206K |
|
1923
Protolabs
PRLB
$1.86B
| $247K | ﹤0.01% |
2,032
-69
| -3% | -$11.5K |
|
1924
United Therapeutics
UTHR
$26.3B
| $247K | ﹤0.01% |
+1,476
| New | +$246K |
|
1925
Invesco NASDAQ Internet ETF
PNQI
$501M
| $246K | ﹤0.01% |
5,340
-30
| -0.6% | -$1.43K |
|
Similar funds
Creative Planning's Q1 2021 Portfolio in Review
As of Q1 2021, Creative Planning held 2,801 positions worth $49.6B, up 9.2% from $45.5B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Creative Planning deployed $2.12B of net new capital in Q1 2021, opening 460 new positions and adding to 1,171 existing holdings. Its largest new stake was Broadstone Net Lease: 1,979,085 shares worth $36.2M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, down from 5.2% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was iShares 3-7 Year Treasury Bond ETF, an estimated $57M trimmed.
- Creative Planning's largest Q1 2021 buy was Broadstone Net Lease: 1,979,085 shares worth $36.2M.
- Creative Planning added most to iShares Core S&P 500 ETF in Q1 2021, an estimated $543M increase.
- Creative Planning's biggest Q1 2021 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $57M.
- Creative Planning fully exited Southside Bancshares in Q1 2021, selling an estimated $2.88M.
- Creative Planning's ten largest holdings make up 49% of its $49.6B portfolio in Q1 2021.
- Creative Planning opened 460 new positions and closed 196 in Q1 2021.
- Creative Planning's portfolio value rose 9.2% quarter-over-quarter to $49.6B.
Based on Creative Planning's 13F filing for Q1 2021, filed 30 Apr 2021.